133 related articles for article (PubMed ID: 28970697)
1. HIV risk associated with nucleic acid testing tested seronegative blood donation where the donor was not preassessed for the risk.
Ghosh K; Misra K
Asian J Transfus Sci; 2017; 11(2):213-214. PubMed ID: 28970697
[No Abstract] [Full Text] [Related]
2. Assessment of HIV transfusion transmission risk in South Africa: a 10-year analysis following implementation of individual donation nucleic acid amplification technology testing and donor demographics eligibility changes.
Vermeulen M; Lelie N; Coleman C; Sykes W; Jacobs G; Swanevelder R; Busch M; van Zyl G; Grebe E; Welte A; Reddy R
Transfusion; 2019 Jan; 59(1):267-276. PubMed ID: 30265757
[TBL] [Abstract][Full Text] [Related]
3. [The results of nucleic acid testing for viruses in individual donor test and its importance for the safety of blood].
Kalibatas V
Medicina (Kaunas); 2008; 44(10):791-8. PubMed ID: 19001837
[TBL] [Abstract][Full Text] [Related]
4. Donation deferral criteria for human immunodeficiency virus positivity among blood donors in northern Thailand.
Sawanpanyalert P; Uthaivoravit W; Yanai H; Limpakarnjanarat K; Mastro TD; Nelson KE
Transfusion; 1996 Mar; 36(3):242-9. PubMed ID: 8604510
[TBL] [Abstract][Full Text] [Related]
5. The History and Challenges of Blood Donor Screening in China.
Li L; Li KY; Yan K; Ou G; Li W; Wang J; Song N; Tian L; Ji X; Chen Y; Liang X; Liu Z; Wu Y
Transfus Med Rev; 2017 Apr; 31(2):89-93. PubMed ID: 28012709
[TBL] [Abstract][Full Text] [Related]
6. Initial trends of individual donation nucleic acid testing in voluntary & replacement donors from a tertiary care centre in north India.
Hans R; Marwaha N; Sharma S; Sachdev S; Sharma RR
Indian J Med Res; 2019 May; 149(5):633-640. PubMed ID: 31417031
[TBL] [Abstract][Full Text] [Related]
7. The risk of transmitting HCV, HBV or HIV by blood transfusion in Victoria.
Whyte GS; Savoia HF
Med J Aust; 1997 Jun; 166(11):584-6. PubMed ID: 9201178
[TBL] [Abstract][Full Text] [Related]
8. Mini-pool screening by nucleic acid testing for hepatitis B virus, hepatitis C virus, and HIV: preliminary results.
Cardoso MS; Koerner K; Kubanek B
Transfusion; 1998 Oct; 38(10):905-7. PubMed ID: 9767739
[TBL] [Abstract][Full Text] [Related]
9. Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period.
Ling AE; Robbins KE; Brown TM; Dunmire V; Thoe SY; Wong SY; Leo YS; Teo D; Gallarda J; Phelps B; Chamberland ME; Busch MP; Folks TM; Kalish ML
JAMA; 2000 Jul; 284(2):210-4. PubMed ID: 10889595
[TBL] [Abstract][Full Text] [Related]
10. Transfusion Transmissible Infections: Maximizing Donor Surveillance.
Awan SA; Junaid A; Sheikh S
Cureus; 2018 Dec; 10(12):e3787. PubMed ID: 30868001
[TBL] [Abstract][Full Text] [Related]
11. Use of nucleic acid testing for blood donor screening of human immunodeficiency virus and hepatitis C virus in the Saudi population.
Akhter J; Roberts GT; Perry A; Gaucher JS; Howman PA
Saudi Med J; 2001 Dec; 22(12):1073-5. PubMed ID: 11802179
[TBL] [Abstract][Full Text] [Related]
12. Modeling complete removal of risk assessment questions in the USA predicts the risk of HIV exposure in blood recipients could increase despite the use of nucleic acid testing.
Yang H; Anderson SA; Forshee R; Williams A; Epstein JS; Marks PW
Vox Sang; 2016 May; 110(4):324-8. PubMed ID: 26765975
[TBL] [Abstract][Full Text] [Related]
13. The results of nucleic acid testing in remunerated and non-remunerated blood donors in Lithuania.
Kalibatas V; Kalibatienė L
Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s58-62. PubMed ID: 24120587
[TBL] [Abstract][Full Text] [Related]
14. The epidemiology of HIV transmission among paid plasma donors, Mexico City, Mexico.
Avila C; Stetler HC; Sepúlveda J; Dickinson E; Castro KG; Ward JW; Romero G; Valdespino JL
AIDS; 1989 Oct; 3(10):631-3. PubMed ID: 2512956
[TBL] [Abstract][Full Text] [Related]
15. Transfusion of HIV-infected blood products despite highly sensitive nucleic acid testing.
Cappy P; Barlet V; Lucas Q; Tinard X; Pillonel J; Gross S; Tiberghien P; Laperche S
Transfusion; 2019 Jun; 59(6):2046-2053. PubMed ID: 30784073
[TBL] [Abstract][Full Text] [Related]
16. HIV and hepatitis C virus RNA in seronegative organ and tissue donors.
Challine D; Pellegrin B; Bouvier-Alias M; Rigot P; Laperche L; Pawlotsky JM
Lancet; 2004 Oct 30-Nov 5; 364(9445):1611-2. PubMed ID: 15519632
[TBL] [Abstract][Full Text] [Related]
17. Self-reported historic human immunodeficiency virus (HIV) testing in a Brazilian blood donor HIV case-control study.
Bruhn R; Moreno E; Sabino EC; Ferreira NA; Carneiro-Proietti AB; Lopes ME; Sampaio D; Loureiro P; Custer B; Goncalez TT;
Transfusion; 2016 Nov; 56(11):2857-2867. PubMed ID: 27716930
[TBL] [Abstract][Full Text] [Related]
18. NAT positivity in seronegative voluntary blood donors from western India.
Mishra KK; Trivedi A; Sosa S; Patel K; Ghosh K
Transfus Apher Sci; 2017 Apr; 56(2):175-178. PubMed ID: 28041821
[TBL] [Abstract][Full Text] [Related]
19. One window-period donation in two years of individual donor-nucleic acid test screening for hepatitis B, hepatitis C and human immunodeficiency virus.
Levi JE; Pereira RA; Polite MB; Mota MA; Nunez SP; Pinho JR; Kutner JM
Rev Bras Hematol Hemoter; 2013; 35(3):167-70. PubMed ID: 23904804
[TBL] [Abstract][Full Text] [Related]
20. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
Hitzler WE
Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
